2-[(2-Methylpropoxy)methyl]oxirane → HCID 57661955, compound
Reaction equation
[NH:1]1[CH2:6][CH2:5][C:4]2([O:11][C:10]3[C:12]4[C:17]([C:18](=[O:21])[C:19](=[O:20])[C:9]=3[S:8][CH2:7]2)=[CH:16][CH:15]=[CH:14][CH:13]=4)[CH2:3][CH2:2]1.[CH2:22]([O:26][CH2:27][CH:28]1[CH2:30][O:29]1)[CH:23]([CH3:25])[CH3:24]>>[OH:29][CH:28]([CH2:27][O:26][CH2:22][CH:23]([CH3:25])[CH3:24])[CH2:30][N:1]1[CH2:2][CH2:3][C:4]2([O:11][C:10]3[C:12]4[C:17]([C:18](=[O:21])[C:19](=[O:20])[C:9]=3[S:8][CH2:7]2)=[CH:16][CH:15]=[CH:14][CH:13]=4)[CH2:5][CH2:6]1Participants
3
Procedure
Compound 174 was synthesized using spiro[naphtho[1,2-b][1,4]oxathiine-2,4′-piperidine]-5,6-dione, 2-(isobutoxymethyl)oxirane and conditions outlined in procedure X. LCMS: 432 [M+H]; Rt=0.97 min.
Sources & evidence
- ORD record
- ord-d659b023308f458aafe9f2829f65edda
- Source dataset
- uspto-grants-2011_10
- Patent number
- US08039503B2
Reaction notes
Loading…